Search
Bio-Techne Corp
TECHAdd to Watchlist
72.200USD
+0.080+0.11%
Market hours 09/14, 14:33（ET）
11.27BMarket Cap
102.30P/E TTM
More Details of Bio-Techne Corp Company
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
Bio-Techne Corp Profile
Ticker SymbolTECH
Company nameBio-Techne Corp
IPO dateFeb 09, 1989
CEOKelderman (Kim)
Number of employees3100
Security typeOrdinary Share
Fiscal year-endFeb 09
Address614 Mckinley Pl N E
CityMINNEAPOLIS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55413
Phone16123798854
Websitehttps://www.bio-techne.com/
Ticker SymbolTECH
IPO dateFeb 09, 1989
CEOKelderman (Kim)
Company Executives of Bio-Techne Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
FAQs
Who are the top five shareholders of Bio-Techne Corp?
The top five shareholders of Bio-Techne Corp are: Mr. Kim Kelderman
How many institutions hold shares of Bio-Techne Corp (TECH)?
As of 2026Q1, 1247 institutions hold shares of Bio-Techne Corp, with a combined market value of approximately 178.19M, accounting for 113.81% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1433.00.
What is the biggest source of revenue for Bio-Techne Corp?
In 2026Q1, the Consumables business generated the highest revenue for Bio-Techne Corp, amounting to 985.12M and accounting for 81.08% of total revenue.